Arylamine N-acetyltransferase (NAT2) genotypes in Africans:: the identification of a new allele with nucleotide changes 481C>T and 590G>A

被引:35
作者
Dandara, C
Masimirembwa, CM
Magimba, A
Kaaya, S
Sayi, J
Sommers, DK
Snyman, JR
Hasler, JA
机构
[1] Univ Zimbabwe, Dept Biochem, Harare, Zimbabwe
[2] Muhimbili Coll Hlth Sci, Dept Pharmacol, Dar Es Salaam, Tanzania
[3] Univ Pretoria, Dept Pharmacol, ZA-0001 Pretoria, South Africa
来源
PHARMACOGENETICS | 2003年 / 13卷 / 01期
关键词
genetic polymorphism; African populations; N-acetyltransferase;
D O I
10.1097/00008571-200301000-00008
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
This study was carried out to characterize the distribution of NAT2 allelic variants among a sample of three African populations. We determined the frequencies of major NAT2 allele clusters (NAT2*5, * 6, * 7 and * 14) using PCR/restriction fragment length polymorphism and sequencing techniques. The genotypes predict slow acetylator phenotypes of 49, 38 and 52% among Tanzanians, Venda and Zimbabweans, respectively. The most common genotype was NAT2*4/*5. NAT2*5 was the most common allele while NAT2*7 was the least common. A new allele with two base changes occurring together, 481 C>T and 590G>A, is reported. The frequency of the occurrence of the combination 481 C>T and 590G>A, was found to be 9% (30/326),7% (14/192) and 8% (18/234) among Zimbabweans, Venda and Tanzanians, respectively. The allele has been named NAT2*6E. Among Africans, the change 481 C>T is not only associated with 341 C>T (i.e. the NAT2*5 allele cluster) as in other populations, but also with 590G>A on the same allele.
引用
收藏
页码:55 / 58
页数:4
相关论文
共 11 条
[1]   AN IMPROVED METHOD FOR GENOTYPING OF N-ACETYLTRANSFERASE POLYMORPHISM BY POLYMERASE CHAIN-REACTION [J].
ABE, M ;
SUZUKI, T ;
DEGUCHI, T .
JAPANESE JOURNAL OF HUMAN GENETICS, 1993, 38 (02) :163-168
[2]   GENOTYPE-PHENOTYPE DISCORDANCE FOR HUMAN ARYLAMINE N-ACETYLTRANSFERASE (NAT2) REVEALS A NEW SLOW-ACETYLATOR ALLELE COMMON IN AFRICAN-AMERICANS [J].
BELL, DA ;
TAYLOR, JA ;
BUTLER, MA ;
STEPHENS, EA ;
WIEST, J ;
BRUBAKER, LH ;
KADLUBAR, FF ;
LUCIER, GW .
CARCINOGENESIS, 1993, 14 (08) :1689-1692
[3]   Genotyping of the polymorphic N-acetyltransferase (NAT2*) gene locus in two native African populations [J].
Delomenie, C ;
Sica, L ;
Grant, DM ;
Krishnamoorthy, R ;
Dupret, JM .
PHARMACOGENETICS, 1996, 6 (02) :177-185
[4]   DETERMINATION OF HUMAN NAT2 ACETYLATOR GENOTYPE BY RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM AND ALLELE-SPECIFIC AMPLIFICATION [J].
DOLL, MA ;
FRETLAND, AJ ;
DEITZ, AC ;
HEIN, DW .
ANALYTICAL BIOCHEMISTRY, 1995, 231 (02) :413-420
[5]  
FERGUSON RJ, 1994, DRUG METAB DISPOS, V22, P371
[6]   Pharmacogenetics of the human arylamine N-acetyltransferases [J].
Grant, DM ;
Goodfellow, GH ;
Sugamori, KS ;
Durette, K .
PHARMACOLOGY, 2000, 61 (03) :204-211
[7]   PARAMETERS AFFECTING THE YIELD OF DNA FROM HUMAN-BLOOD [J].
GUSTAFSON, S ;
PROPER, JA ;
BOWIE, EJW ;
SOMMER, SS .
ANALYTICAL BIOCHEMISTRY, 1987, 165 (02) :294-299
[8]  
Shishikura K, 2000, Hum Mutat, V15, P581, DOI 10.1002/1098-1004(200006)15:6<581::AID-HUMU17>3.0.CO
[9]  
2-V
[10]   NOMENCLATURE FOR N-ACETYLTRANSFERASES [J].
VATSIS, KP ;
WEBER, WW ;
BELL, DA ;
DUPRET, JM ;
EVANS, DAP ;
GRANT, DM ;
HEIN, DW ;
LIN, HJ ;
MEYER, UA ;
RELLING, MV ;
SIM, E ;
SUZUKI, T ;
YAMAZOE, Y .
PHARMACOGENETICS, 1995, 5 (01) :1-17